Home / News

News

Tête à Tête décideurs – Pierre Langlade Demoyen, ...

Invectys : lutter contre toutes les formes de cancers Avec 382 000 nouveaux cas et 157 400 décès par an, le cancer demeure une priorité absolue en matière de…

Read more

2019 ESMO Immuno-Oncology Congress

ESMO Immuno-Oncology Congress 2019 December 11th – 14th 2019 Palexpo, Geneva, Switzerland Invectys will be attending the 2019 ESMO Immuno-Oncology Congress. From…

Read more

8th International Conference on HLA-G

8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…

Read more

Invectys élu meilleur projet 2019 par le Board de MATWIN

Invectys élu « meilleur projet – jeune entreprise » 2019 par le Board international de MATWIN Invectys, société biopharmaceutique développant des thérapies…

Read more

Healthtech Investor Days 2019, Paris, June 24-25

  Healthtech Investor Day June 24th – 25th, 2019 The Peninsula Paris, Paris, France   Pierre Langlade-Demoyen, our CEO, will be representing Invectys…

Read more

BIO International Convention 2019, Philadelphia, June 3-6

Bio International Convention 2019 June 3 – 6th 2019 Pennsylvania Convention Center, Philadelphia, Pennsylvania, USA   Invectys will be attending the BIO International…

Read more

ASCO Annual Meeting, Chicago, May 31 – June 4

  ASCO Annual meeting 2019 May 31st – June 4th 2019 McCormick Place, Chicago, Illinois, USA   Invectys will be attending the 2019 ASCO Annual Meeting,…

Read more

ICVI International Symposium on Immunotherapy, 2019

  ICVI International Symposium on Immunotherapy May 24th – 25th, 2019 The Royal Society, London, UK   Invectys will be attending the Institute for…

Read more